Breaking News
Sort by:
Date
Top Post
CNS Pharmaceuticals Announces First Patient Enrolled in Spain in Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM
CNS Pharmaceuticals, a biopharmaceutical company specializing in the development of novel treatments for primary and […]
Transine Therapeutics Announces Final Closing of its Seed Round at £13.7m to Accelerate its Platform and Portfolio Development
Transine Therapeutics (‘Transine’), a biotechnology company developing a novel class of therapeutic RNAs based on […]
Transine Therapeutics Appoints Industry Veteran Jan Thirkettle Ph.D. as CEO
Transine Therapeutics, a biotechnology company developing a novel class of therapeutic RNAs based on its […]
- Immunome Announces Formation of Antibody-Drug Conjugate and T Cell Redirection Advisory Board Read more
- Toragen Announces Appointment of Chief Scientific Officer Read more
- First Citizens Bank Provides $31.2 Million for Acquisition of Cancer Treatment Center in Columbia, South Carolina Read more
- Roche Expands Collaboration with Janssen to Advance Personalised Healthcare Through Companion Diagnostics Read more
- ReviR Therapeutics and Asieris Pharmaceuticals Enter into Agreement to Discover Oncology Therapeutics Read more